MICB and neoplasm: Moreover, in colon carcinoma and sarcoma cells, treatment with HDAC inhibitor Entinostat, a class I HDAC1 and HDAC3 inhibitor, led to increase in expression of NKG2D ligand MICA and MICB, enhancing cytotoxicity of NK cells against tumor cells (25).